Publication: Elevated F<inf>2</inf>-isoprostanes in thalassemic patients
Issued Date
2007-12-15
Resource Type
ISSN
08915849
Other identifier(s)
2-s2.0-36248946663
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Free Radical Biology and Medicine. Vol.43, No.12 (2007), 1649-1655
Suggested Citation
Chutima Matayatsuk, Chung Yung J. Lee, Ruchaneekorn W. Kalpravidh, Pornpan Sirankapracha, Prapin Wilairat, Suthat Fucharoen, Barry Halliwell Elevated F<inf>2</inf>-isoprostanes in thalassemic patients. Free Radical Biology and Medicine. Vol.43, No.12 (2007), 1649-1655. doi:10.1016/j.freeradbiomed.2007.08.026 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/24061
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Elevated F<inf>2</inf>-isoprostanes in thalassemic patients
Abstract
This study was aimed at investigating oxidative stress in thalassemic patients by measurement of the oxidative damage biomarker, F2-isoprostanes (F2-IsoPs), using gas chromatography-mass spectrometry. The results showed that the mean value of urinary F2-IsoPs, normalized with creatinine, in the thalassemic group was significantly higher than that from healthy subjects (3.38 ± 2.15 ng/mg creatinine vs 0.86 ± 0.55 ng/mg creatinine, respectively), and the mean value of plasma total F2-IsoPs in the thalassemic group was also significantly higher than that from healthy subjects (0.39 ± 0.15 ng/ml vs 0.18 ± 0.03 ng/ml, respectively). Serum ferritin, erythrocyte superoxide dismutase (SOD), glutathione peroxidase, glutathione, and TBARS levels after treatment of erythrocytes with H2O2were also investigated, and serum ferritin and erythrocyte SOD levels were significantly higher in thalassemic patients. Our findings are consistent with oxidative stress in thalassemia patients. © 2007 Elsevier Inc. All rights reserved.